Why the HHS Two-Part Test Is Now Influencing DEA Scheduling Decisions By Jason Karimi The Controlled Substances Act (CSA) has long required that a drug must have a “currently accepted medical use in treatment in the United States” before it can be placed outside of Schedule I. For decades, that determination was interpreted by the … Continue reading A New Legal Standard Emerges: How HHS’s Two-Part Test Is Reshaping DEA Drug Scheduling